Cytovance in Agreement with Akshaya
The Journal Record website reported that Cytovance Biologics has entered into a collaboration agreement with Akshaya Bio Inc. to provide rapid access to clinical materials using Akshaya’s proprietary Chimigen Platform Technology for vaccine development for COVID-19 and hepatitis B vaccine. Oklahoma City-based Cytovance Biologics is a contract development
Comments Off on Cytovance in Agreement with Akshaya • Read this story »
More Articles
Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
The GlobalNewswire website noted that a new study has been released reporting that the growing adoption of open innovation models in pharmaceutical and biotechnology companies and increasing pharmaceutical outsourcing are the key factors driving the growth of the protein stability analysis market. The
Comments Off on Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies • Read this story »
Evotec, Sanofi on Infectious Disease Research Agreement
The Pharmaceutical Business Review website reported that the major drug companies Evotec and Sanofi are in exclusive negotiations to create an infectious disease open innovation research and development platform through a new open innovation platform near Lyon in France. The platform will be led by
Comments Off on Evotec, Sanofi on Infectious Disease Research Agreement • Read this story »
Technology Based Firms, Strategic Alliances and Open Innovation
An article in the Journal of Global Entrepreneurship Research examines the impact of strategic partnerships and open innovation on the success of new biotechnology firms by developing multiple case studies of firms in regional biotechnology clusters. The study finds that, despite their small size and
Comments Off on Technology Based Firms, Strategic Alliances and Open Innovation • Read this story »
Pharma Industry Continues Building Open Innovation Models
The Nature Biotechnology website reports that seven large pharma companies and a biotech firm, Alnylam, have formed a collaboration with the World Intellectual Property Organisation (WIPO) to establish WIPO Re:Search. This open innovation initiative lines up United Nations agency WIPO of Geneva with